Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Oreopoulos

Showing results (171-180 of 357) with videos related to

Pageof 36
Sort By:
Canadian Medical Association Journal|January 1, 1981
For how long can peritoneal dialysis be continued?D G Oreopoulos, L Gotloib, V Calderaro, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1985
Spontaneous remission of nephrotic syndrome in IgA glomerular diseaseG Wu, A Katz, C Cardella, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 12, 1999
l-2-oxothiazolidine-4-carboxylic acid modulates function of peritoneal mesothelial cells in vitroA Breborowicz, J Wisniewska, J B Moberly, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Urea kinetics has limited relevance in assessing adequacy of dialysis in CAPDP G Blake, E Balaskas, R Blake, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1993
Renal replacement therapies in the elderly: Part 1. Hemodialysis and chronic peritoneal dialysisN Ismail, R M Hakim, D G Oreopoulos, et al.
Advances in Renal Replacement Therapy|August 1, 1998
Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literatureI E Afthentopoulos, P Passadakis, D G Oreopoulos, et al.
The International Journal of Artificial Organs|March 17, 2005
Atorvastatin improves peritoneal sclerosis induced by hypertonic PD solution in ratsS Duman, S Sen, E Y Sozmen, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|August 21, 2001
A comparison of the biocompatibility of phosphate-buffered saline and dianeal 3.86% in the rat model of peritoneal dialysisK Wieczorowska-Tobis, A Polubinska, A Breborowicz, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 1, 1979
Studies of crystalluria in recurrent calcium lithiasisP O Crassweller, L Brandes, A Katirtzoglou, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 13, 2002
Comparison of the biocompatibility of phosphate-buffered saline alone, phosphate-buffered saline supplemented with glucose, and dianeal 3.86%K Wieczorowska-Tobis, A Styszynski, A Breborowicz, et al.
Pageof 36

Showing results (171-180 of 357) with videos related to

Sort By:
Pageof 36
Canadian Medical Association Journal|January 1, 1981
For how long can peritoneal dialysis be continued?D G Oreopoulos, L Gotloib, V Calderaro, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1985
Spontaneous remission of nephrotic syndrome in IgA glomerular diseaseG Wu, A Katz, C Cardella, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 12, 1999
l-2-oxothiazolidine-4-carboxylic acid modulates function of peritoneal mesothelial cells in vitroA Breborowicz, J Wisniewska, J B Moberly, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Urea kinetics has limited relevance in assessing adequacy of dialysis in CAPDP G Blake, E Balaskas, R Blake, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1993
Renal replacement therapies in the elderly: Part 1. Hemodialysis and chronic peritoneal dialysisN Ismail, R M Hakim, D G Oreopoulos, et al.
Advances in Renal Replacement Therapy|August 1, 1998
Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literatureI E Afthentopoulos, P Passadakis, D G Oreopoulos, et al.
The International Journal of Artificial Organs|March 17, 2005
Atorvastatin improves peritoneal sclerosis induced by hypertonic PD solution in ratsS Duman, S Sen, E Y Sozmen, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|August 21, 2001
A comparison of the biocompatibility of phosphate-buffered saline and dianeal 3.86% in the rat model of peritoneal dialysisK Wieczorowska-Tobis, A Polubinska, A Breborowicz, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 1, 1979
Studies of crystalluria in recurrent calcium lithiasisP O Crassweller, L Brandes, A Katirtzoglou, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 13, 2002
Comparison of the biocompatibility of phosphate-buffered saline alone, phosphate-buffered saline supplemented with glucose, and dianeal 3.86%K Wieczorowska-Tobis, A Styszynski, A Breborowicz, et al.
Pageof 36